{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:12:15Z","timestamp":1757617935496,"version":"3.44.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970114","8160010893"],"award-info":[{"award-number":["81970114","8160010893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12014118"],"award-info":[{"award-number":["SHDC12014118"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12185-025-03971-9","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:34:18Z","timestamp":1747960458000},"page":"267-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early withdrawal immunosuppression improved mixed chimerism in stem cell transplantation for pediatric aplastic anemia"],"prefix":"10.1007","volume":"122","author":[{"given":"Xinan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-700X","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"1","key":"3971_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43\u201370.","journal-title":"Br J Haematol"},{"issue":"9","key":"3971_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-018-0716-8","volume":"20","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Kojima S. Updated guidelines for the treatment of acquired aplastic anemia in children. Curr Oncol Rep. 2018;20(9):67.","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"3971_CR3","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00277-021-04540-w","volume":"100","author":"X Qin","year":"2021","unstructured":"Qin X, Zhu YP, Luo CJ, Zhou M, Huang K, Chen C, et al. Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6\u20137\/8 HLA-matched donor comparable to that from an 8\/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years. Ann Hematol. 2021;100(9):2363\u201373.","journal-title":"Ann Hematol"},{"issue":"17","key":"3971_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643\u201356.","journal-title":"N Engl J Med"},{"issue":"6","key":"3971_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120(6):1185\u201396.","journal-title":"Blood"},{"issue":"16","key":"3971_CR6","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376(16):1540\u201350.","journal-title":"N Engl J Med"},{"issue":"5","key":"3971_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1365-2141.2005.05667.x","volume":"130","author":"C Kahl","year":"2005","unstructured":"Kahl C, Leisenring W, Deeg HJ, Chauncey TR, Flowers ME, Martin PJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol. 2005;130(5):747\u201351.","journal-title":"Br J Haematol"},{"issue":"6","key":"3971_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3324\/haematol.2009.018267","volume":"95","author":"A Bacigalupo","year":"2010","unstructured":"Bacigalupo A, Socie G, Lanino E, Prete A, Locatelli F, Locasciulli A, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010;95(6):976\u201382.","journal-title":"Haematologica"},{"issue":"1","key":"3971_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2141.2012.09058.x","volume":"157","author":"S Samarasinghe","year":"2012","unstructured":"Samarasinghe S, Webb DK. How I manage aplastic anaemia in children. Br J Haematol. 2012;157(1):26\u201340.","journal-title":"Br J Haematol"},{"issue":"20","key":"3971_CR10","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","volume":"3","author":"N Bejanyan","year":"2019","unstructured":"Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, et al. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019;3(20):3123\u201331.","journal-title":"Blood Adv"},{"issue":"6","key":"3971_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1365-2141.2008.07533.x","volume":"144","author":"M Lawler","year":"2009","unstructured":"Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol. 2009;144(6):933\u201345.","journal-title":"Br J Haematol"},{"issue":"3","key":"3971_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12185-014-1501-6","volume":"99","author":"M Ashizawa","year":"2014","unstructured":"Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, et al. A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia. Int J Hematol. 2014;99(3):311\u20137.","journal-title":"Int J Hematol"},{"issue":"2","key":"3971_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbmt.2014.10.010","volume":"21","author":"HL Haines","year":"2015","unstructured":"Haines HL, Bleesing JJ, Davies SM, Hornung L, Jordan MB, Marsh RA, et al. Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases. Biol Blood Marrow Transplant. 2015;21(2):288\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3971_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101076","volume":"60","author":"KF Muskens","year":"2023","unstructured":"Muskens KF, Lindemans CA, Dandis R, Nierkens S, Belderbos ME. Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: A systematic review and meta-analysis. Blood Rev. 2023;60: 101076.","journal-title":"Blood Rev"},{"issue":"6","key":"3971_CR15","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"3971_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945\u201356.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"3971_CR17","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","volume":"55","author":"G ElGohary","year":"2020","unstructured":"ElGohary G, El Fakih R, de Latour R, Risitano A, Marsh J, Schrezenmeier H, et al. Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT). Bone Marrow Transplant. 2020;55(10):1906\u201317.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3971_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/bjh.13297","volume":"169","author":"C Dufour","year":"2015","unstructured":"Dufour C, Pillon M, Socie G, Rovo A, Carraro E, Bacigalupo A, et al. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol. 2015;169(4):565\u201373.","journal-title":"Br J Haematol"},{"key":"3971_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12185-023-03564-4","volume":"119","author":"N Yoshida","year":"2023","unstructured":"Yoshida N. Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia. Int J Hematol. 2023;119:240\u20137.","journal-title":"Int J Hematol"},{"issue":"5","key":"3971_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/bmt.2012.205","volume":"48","author":"A Kikuchi","year":"2013","unstructured":"Kikuchi A, Yabe H, Kato K, Koh K, Inagaki J, Sasahara Y, et al. Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan. Bone Marrow Transplant. 2013;48(5):657\u201360.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"3971_CR21","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3324\/haematol.2018.206540","volume":"104","author":"ZR Rogers","year":"2019","unstructured":"Rogers ZR, Nakano TA, Olson TS, Bertuch AA, Wang W, Gillio A, et al. Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study. Haematologica. 2019;104(10):1974\u201383.","journal-title":"Haematologica"},{"key":"3971_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.889784","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen X, Li L, Li Y, Lin L, Cao Y, et al. Retrospective comparison of efficacy and safety of rabbit anti-thymocyte globulin and porcine anti-lymphocyte globulin in patients with acquired aplastic anemia undergoing hematopoietic stem cell transplantation from matched sibling donors. Front Immunol. 2022;13: 889784.","journal-title":"Front Immunol"},{"issue":"5","key":"3971_CR23","doi-asserted-by":"publisher","first-page":"322.e1","DOI":"10.1016\/j.jtct.2023.01.016","volume":"29","author":"P Chorao","year":"2023","unstructured":"Chorao P, Montoro J, Balaguer-Rosello A, Guerreiro M, Villalba M, Facal A, et al. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia. Transplant Cell Ther. 2023;29(5):322.e1-322.e5.","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"3971_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1182\/blood.V84.3.941.941","volume":"1","author":"R Storb","year":"1994","unstructured":"Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, et al. Cyclophosphamide Combined With Antithymocyte Globulin in Preparation for Allogeneic Marrow Transplants in Patients With Aplastic Anemia. Blood. 1994;1(3):941\u20139.","journal-title":"Blood"},{"issue":"11","key":"3971_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.bmt.1704720","volume":"34","author":"HJ Kang","year":"2004","unstructured":"Kang HJ, Shin HY, Choi HS, Ahn HS. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant. 2004;34(11):939\u201343.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3971_CR26","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med. 1981;141(6):758\u201363.","journal-title":"Arch Intern Med"},{"issue":"7","key":"3971_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbmt.2012.04.014","volume":"18","author":"J Tolar","year":"2012","unstructured":"Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, et al. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. Biol Blood Marrow Transplant. 2012;18(7):1007\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"3971_CR28","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","volume":"2","author":"P Anderlini","year":"2015","unstructured":"Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, et al. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1\u20132 dose de-escalation study. Lancet Haematol. 2015;2(9):e367\u201375.","journal-title":"Lancet Haematol"},{"issue":"7","key":"3971_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41409-020-0948-8","volume":"55","author":"N Yoshida","year":"2020","unstructured":"Yoshida N, Takahashi Y, Yabe H, Kobayashi R, Watanabe K, Kudo K, et al. Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine\/melphalan vs. fludarabine\/cyclophosphamide. Bone Marrow Transplant. 2020;55(7):1272\u201381.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3971_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajh.25693","volume":"95","author":"S Kako","year":"2020","unstructured":"Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, et al. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. Am J Hematol. 2020;95(3):251\u20137.","journal-title":"Am J Hematol"},{"issue":"2","key":"3971_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.bmt.1704715","volume":"35","author":"P Bader","year":"2005","unstructured":"Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingebiel T. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant. 2005;35(2):107\u201319.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3971_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V67.3.811.811","volume":"67","author":"RS Hill","year":"1986","unstructured":"Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67(3):811\u20136.","journal-title":"Blood"},{"issue":"1","key":"3971_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/16078454.2021.1938422","volume":"26","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li Y, Wu L, Zhou M, Wang C, Mo W, et al. Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Hematology. 2021;26(1):435\u201343.","journal-title":"Hematology"},{"issue":"5","key":"3971_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.bbmt.2018.01.011","volume":"24","author":"YL Kasamon","year":"2018","unstructured":"Kasamon YL, Fuchs EJ, Zahurak M, Rosner GL, Symons HJ, Gladstone DE, et al. Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation. Biol Blood Marrow Transplant. 2018;24(5):1022\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"3971_CR35","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.bbmt.2020.07.037","volume":"26","author":"AE DeZern","year":"2020","unstructured":"DeZern AE, Elmariah H, Zahurak M, Rosner GL, Gladstone DE, Ali SA, et al. Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide. Biol Blood Marrow Transplant. 2020;26(11):2075\u201381.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"3971_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"MA Kharfan-Dabaja","year":"2021","unstructured":"Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, et al. Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the american society for transplantation and cellular therapy. Transplant Cellular Ther. 2021;27(8):642\u20139.","journal-title":"Transplant Cellular Ther"},{"issue":"7","key":"3971_CR37","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","volume":"80","author":"RA Nash","year":"1992","unstructured":"Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood. 1992;80(7):1838\u201345.","journal-title":"Blood"},{"issue":"9","key":"3971_CR38","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.17219\/acem\/103069","volume":"28","author":"Z Szmit","year":"2019","unstructured":"Szmit Z, Kalwak K, Krol A, Mielcarek-Siedziuk M, Salamonowicz M, Fraczkiewicz J, et al. Premature cyclosporine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation. Adv Clin Exp Med. 2019;28(9):1185\u201392.","journal-title":"Adv Clin Exp Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03971-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03971-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03971-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:18:20Z","timestamp":1757171900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03971-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3971"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03971-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no potential competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All parents, guardians and children over 8\u00a0years old provided informed consent in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}